NASDAQ:CHFS
Delisted
CHF Solutions Inc Stock News
$1.00
+0 (+0%)
At Close: Aug 17, 2022
CHF Solutions Expands Access to Ultrafiltration Therapy for Pediatric Patients in Two Texas Hospitals
08:00am, Friday, 23'rd Apr 2021
EDEN PRAIRIE, Minn., April 23, 2021 (GLOBE NEWSWIRE) -- Improving access to life-saving fluid management therapies is a commitment CHF Solutions (Nasdaq: CHFS) stands by. The company today announced A
A Trio of Net Current Asset Value Stock Picks
12:35pm, Tuesday, 13'th Apr 2021
Short-term investors may want to have a look at these businesses
New Clinical Abstract Available Online During National Kidney Foundation Spring Clinical Meeting (NKF) New Clinical Abstract Available Online During National Kidney Foundation Spring Clinical Meeting
EDEN PRAIRIE, Minn., March 19, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) today announced the closing of its previously announced underwritten public offering of 3,
CHF Solutions, Inc. Announces Proposed Underwritten Public Offering of Common Stock
04:05pm, Tuesday, 16'th Mar 2021
EDEN PRAIRIE, Minn., March 16, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) announced today that it intends to offer shares of its common stock in an underwritten pub
CHF Solutions Submits Patent Application for New Peripheral Venous Access Technology for Ultrafiltration and CRRT Systems
08:00am, Thursday, 11'th Mar 2021
EDEN PRAIRIE, Minn., March 11, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announce
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05:00pm, Friday, 05'th Mar 2021
EDEN PRAIRIE, Minn., March 05, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, effective February 17, 2021, the independent directors approved one equity award under
ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery Patients
08:00am, Thursday, 04'th Mar 2021
EDEN PRAIRIE, Minn., March 04, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, will participa
CHF Solutions' (CHFS) CEO Nestor Jaramillo on Q4 2020 Results - Earnings Call Transcript
03:04pm, Tuesday, 02'nd Mar 2021
CHF Solutions' (CHFS) CEO Nestor Jaramillo on Q4 2020 Results - Earnings Call Transcript
CHFS Stock Price Increases Over 15% Pre-Market: Why It Happened
08:29am, Tuesday, 02'nd Mar 2021
The stock price of CHF Solutions Inc (NASDAQ: CHFS) is trading at over 15% pre-market. This is why it happened.
EDEN PRAIRIE, Minn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced
CHF Solutions Offers Educational Event on Effective Fluid Management Strategies in Heart Failure Patients
08:00am, Thursday, 21'st Jan 2021
EDEN PRAIRIE, Minn., Jan. 21, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced
2 Falling Knives to Catch
10:30am, Friday, 15'th Jan 2021
Wall Street recommends buying shares of CHF Solutions Inc (NASDAQ:CHFS) and Viveve Medical Inc (NASDAQ:VIVE), which sounds quite unexpected since these two stocks performed very poorly over the prior
CHF Solutions Protects New Peripheral Vascular Access Catheter with Patent Application
08:00am, Tuesday, 12'th Jan 2021
EDEN PRAIRIE, Minn., Jan. 12, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced
CHF Solutions Announces Webinar on Pediatric Ultrafiltration Therapy hosted by Ladenburg Thalman & Co.
08:00am, Friday, 04'th Dec 2020
EDEN PRAIRIE, Minn., Dec. 04, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced